| 词条 | Galderma |
| 释义 |
| name = Galderma | logo = Galderma logo.svg | type = Subsidiary of Nestlé | foundation = 1981 | location = Galderma Pharma SA/Galderma SA Lausanne, Switzerland |founder = M. Owen | industry = Dermatology Pharmaceuticals | revenue = €1.7 billion in 2013 | num_employees = +6,000 (2017) | parent = L'Oréal (1981–2014) Nestlé (1981–present) | homepage = www.galderma.com }} Galderma S.A. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments. The company became a wholly owned subsidiary of Nestlé in 2014. AboutGalderma was formed in 1981 as a joint venture between Nestlé and L'Oréal.[1] The company, headed by President & CEO Humberto C. Antunes, has 33 affiliates in 100 countries[2] with a worldwide network of distributors and employs more than 5,000 people. The parent company is based in Lausanne, Switzerland, with Corporate Services in Paris-La Défense, France. The Galderma Code of Ethics[3] lists all applicable legal requirements in the countries where Galderma operates. Galderma S.A. have extensive policies and procedures contained in other supporting documents.[4] talking in terms of environment, social aspects and business ethics.. HistoryThe origins of Galderma date back to 1961 and the founding of the Owen dermatology company in Dallas, Texas, USA by M. Owen. In 2007, the Galderma Global Corporate Campaign won the Medical Marketing Association's International Award of Excellence. In 2010, sales reached 1.2 billion euros, an increase of 16.1% over 2009.{{citation needed|date=February 2013}} In 2011, Galderma acquired Q-Med, a Swedish medical-device company.[5] In 2014, Nestlé bought back all the shares from L'Oréal, thus creating a new unit of Nestlé group called Nestle Skin Health. The transaction had a value of €3.1 billion (US$4.23 billion) and was paid for by Nestlé with 21.2 million L'Oréal shares.[6] L'Oréal paid €3.4 billion (US$4.63 billion) for the remaining 27.3 million shares.[6] ActivitiesGalderma provides a range of products used to treat acne, rosacea, psoriasis and other steroid-responsive dermatoses (SRD), onychomycosis (fungal nail infections), pigmentary disorders, skin cancer and skin senescence. Galderma’s products sell in more than 70 countries. The company invests substantially in research and development and sources new treatments from its own activities and from its partnerships with others. It divides its research and development departments between four sites:
Galderma has manufacturing facilities at the following locations:
The French and Canadian plants have grown in order to improve and increase production capacity.{{citation needed|date=February 2013}} {{As of | 2011}} the four sites combined produced over 100 million units. Notes and references1. ^Nestlé 2. ^{{cite web|url=http://www.galderma.com/OurCompany/GaldermaataGlance.aspx |title=Dermatology company |publisher=Galderma |date= |accessdate=2012-06-10}} 3. ^{{cite web|url=http://www.galderma.com/OurCompany/EthicsValues.aspx |title= Galderma Code Of Ethics|date= |accessdate=2013-02-27}} 4. ^{{cite web|url=http://www.galderma.com/OurCompany/EthicsValues/SupplierCode.aspx |title= Galderma Supplier Code |date= |accessdate=2013-02-27}} 5. ^{{cite web|url=http://www.nestle.com/asset-library/Documents/Library/Documents/Financial_Statements/2012-Financial-Statements-EN.pdf|title= Nestlè Financial Statement 2012|publisher=Galderma |date= |accessdate=2013-02-26}} 6. ^1 {{cite web | url=http://www.wwd.com/beauty-industry-news/financial/loral-to-buy-8-of-share-capital-from-nestl-7438440?src=n/newsAlert/20140211-1 | title=L'Oréal to Buy 8% of Share Capital From Nestlé | publisher=WWD | date=11 February 2014 | accessdate=11 February 2014 | author=Socha, Miles}} See also
4 : Companies based in Lausanne|Pharmaceutical companies of Switzerland|L'Oréal|Nestlé |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。